Nanomaterial-based ophthalmic therapies.

NanomedicineAhead of Print Journal WatchNanomaterial-based ophthalmic therapiesHarald Unterweger, Christina Janko, Mehtap Civelek, Iwona Cicha, Helmut Spielvogel, Rainer Tietze, Bernhard Friedrich & Christoph AlexiouHarald Unterweger https://orcid.org/0000-0002-8335-0692Department of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanySearch for more papers by this author, Christina Janko https://orcid.org/0000-0001-5705-6329Department of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanySearch for more papers by this author, Mehtap CivelekDepartment of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanySearch for more papers by this author, Iwona Cicha https://orcid.org/0000-0002-7399-5307Department of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanySearch for more papers by this author, Helmut SpielvogelDepartment of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanySearch for more papers by this author, Rainer TietzeDepartment of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanySearch for more papers by this author, Bernhard FriedrichDepartment of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanySearch for more papers by this author & Christoph Alexiou *Author for correspondence: Tel.: +49 913 1853 3142; E-mail Address: c.alexiou@web.dehttps://orcid.org/0000-0003-2220-6790Department of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanySearch for more papers by this authorPublished Online:30 Jun 2023https://doi.org/10.2217/nnm-2023-0109AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: age-related macular degenerationdiabetic retinopathyeye infectionsglaucomakeratitisnanoparticlesReferences1. Gote V, Sikder S, Sicotte J, Pal D. Ocular drug delivery: present innovations and future challenges. J. Pharmacol. Exp. Ther. 370(3), 602–624 (2019).Crossref, Medline, CAS, Google Scholar2. Sampat KM, Garg SJ. Complications of intravitreal injections. Curr. Opin. Ophthalmol. 21(3), 178–183 (2010).Crossref, Medline, Google Scholar3. Wong WL, Su X, Li X et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2(2), e106–e116 (2014).Crossref, Medline, Google Scholar4. Ferris FL 3rd, Wilkinson CP, Bird A et al. Clinical classification of age-related macular degeneration. Ophthalmology 120(4), 844–851 (2013).Crossref, Medline, Google Scholar5. Flores R, Carneiro A, Vieira M, Tenreiro S, Seabra MC. Age-related macular degeneration: pathophysiology, management, and future perspectives. Ophthalmologica 244(6), 495–511 (2021).Crossref, Medline, CAS, Google Scholar6. Lin TC, Hung KH, Peng CH et al. Nanotechnology-based drug delivery treatments and specific targeting therapy for age-related macular degeneration. J. Chin. Med. Assoc. 78(11), 635–641 (2015).Crossref, Medline, Google Scholar7. Bourne RRA, Jonas JB, Bron AM et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Brit. J. Ophthalmol. 102(5), 575–585 (2018).Crossref, Medline, Google Scholar8. Boehm BO, Lang G, Feldmann B et al. Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. A pilot study. Horm. Metab. Res. 35(6), 382–386 (2003).Crossref, Medline, CAS, Google Scholar9. Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. Fems. Immunol. Med. Mic. 50(1), 1–26 (2007).Crossref, Medline, CAS, Google Scholar10. Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite 22, 10 (2015).Crossref, Medline, Google Scholar11. CDC. Parasites–Acanthamoeba–granulomatous amebic encephalitis (gae); keratitis (2013). www.cdc.gov/parasites/acanthamoeba/health_professionals/index.html (Accessed 24 March 2023).Google Scholar12. Carnt N, Stapleton F. Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review. Ophthal. Phys. Opt. 36(2), 77–92 (2016).Crossref, Medline, Google Scholar13. Martin-Navarro CM, Lorenzo-Morales J, Machin RP et al. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme a reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections. Antimicrob. Agents Chemother. 57(1), 375–381 (2013).Crossref, Medline, CAS, Google Scholar14. Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121(11), 2081–2090 (2014).Crossref, Medline, Google Scholar15. Peng JJ, Song WT, Yao F et al. Involvement of regulated necrosis in blinding diseases: focus on necroptosis and ferroptosis. Exp. Eye Res. 191, 107922 (2020).Crossref, Medline, CAS, Google Scholar16. Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature 517(7534), 311–320 (2015).Crossref, Medline, CAS, Google Scholar17. Mifflin L, Ofengeim D, Yuan J. Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat. Rev. Drug Discov. 19(8), 553–571 (2020).Crossref, Medline, CAS, Google Scholar18. Das S, Singh S, Kumar A. Bacterial burden declines but neutrophil infiltration and ocular tissue damage persist in experimental Staphylococcus epidermidis endophthalmitis. Front. Cell Infect. Microbiol. 11, 780648 (2021).Crossref, Medline, CAS, Google Scholar19. Sahay P, Goel S, Nagpal R et al. Infectious keratitis caused by rare and emerging micro-organisms. Curr. Eye Res. 45(7), 761–773 (2020).Crossref, Medline, CAS, Google Scholar20. Thomas RK, Melton R, Asbell PA. Antibiotic resistance among ocular pathogens: current trends from the ARMOR surveillance study (2009–2016). Clin. Optom. 11, 15–26 (2019).Crossref, Medline, Google ScholarFiguresReferencesRelatedDetails Ahead of Print STAY CONNECTED Metrics Downloaded 0 times History Received 11 April 2023 Accepted 17 April 2023 Published online 30 June 2023 Information© 2023 Future Medicine LtdKeywordsage-related macular degenerationdiabetic retinopathyeye infectionsglaucomakeratitisnanoparticlesFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download